ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1170

High Output Flow Cytometry Array Classifies Subjects with Uveitis Due to Behcet’s Disease and Sarcoidosis

Johannes Nowatzky1, Ezra Resnick2, Julia Manasson3, Cristy Stagnar1 and Olivier Manches4, 1Department of Medicine, Division of Rheumatology, NYU School of Medicine, New York, NY, 2Google Inc., New York, NY, 3Department of Medicine, Division of Rheumatology, New York University School of Medicine, New York, NY, 4EFS Rhône-Alpes-Auvergne "Immunobiology and Immunotherapy in Chronic Diseases", INSERM - French National Institute of Health and Medical Research, Grenoble, France

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Behcet's syndrome, Big data, flow cytometry, sarcoidosis and uveitis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 6, 2017

Title: Miscellaneous Rheumatic and Inflammatory Diseases Poster I

Session Type: ACR Poster Session B

Session Time: 9:00AM-11:00AM

Background/Purpose: The information content of multi-parametric flow cytometry-based immune-phenotyping experiments is routinely underexploited given the paucity of adequate tools and strategies for large-scale unbiased data analysis.

Methods: We developed and applied a data analysis approach taking into account all mathematically possible combinations of markers in a given flow cytometry panel. We analyzed mined (dx.doi.org/10.5061/dryad.v6st3) flow cytometry data generated from peripheral blood samples of healthy humans and subjects with a uniform ocular patho-phenotype (pan-uveitis) caused by 2 different autoimmune diseases: Behcet’s disease and sarcoidosis. Flow data were gated in bivariate plots. We employed combinatory mathematics to generate a matrix quantifying the representation of all possible cell populations using given sets of markers within the respective starting populations and coded the algorithm in Java. Computed metadata were tested against primary data sets of manually gated cell populations with known markers and immunological properties. External variables defined by biological characteristics of the subjects, i.e., ‘healthy vs diseased’ and ‘Behcet’s uveitis vs Sarcoid uveitis’ were used as independent measures of truth for sample classification.

Results: Our method increased the retrievable information content from each panel exponentially in relation to the number of markers used instead of linearly as in conventional approaches. Computed cell populations matched those in primary data sets. The method enabled clustering of healthy vs diseased subjects using only 4 common markers (CD3, C8, CD197, and CD45), and of sarcoid vs Behcet’s uveitis subjects with minimal error.

Conclusion: Our approach demonstrates that multi-dimensional analysis of flow cytometry data allows meaningful screening of biologically relevant markers enabling classification and characterization of states of health and autoimmune disease. The approach is unbiased and has the potential to facilitate the discovery of cell populations with relevance as potential biomarkers or biological research targets.


Disclosure: J. Nowatzky, None; E. Resnick, None; J. Manasson, None; C. Stagnar, None; O. Manches, None.

To cite this abstract in AMA style:

Nowatzky J, Resnick E, Manasson J, Stagnar C, Manches O. High Output Flow Cytometry Array Classifies Subjects with Uveitis Due to Behcet’s Disease and Sarcoidosis [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/high-output-flow-cytometry-array-classifies-subjects-with-uveitis-due-to-behcets-disease-and-sarcoidosis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/high-output-flow-cytometry-array-classifies-subjects-with-uveitis-due-to-behcets-disease-and-sarcoidosis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology